BridgeMD
New treatment option for Venous Ulcer
Official title Fetal Cell Receptors Repertoire
ClinicalTrials.gov ID: NCT06031714
What this study is testing
- What it's testing
- The purpose of this study is to describe the transcriptomic profile of foetal cells in post-partum and more specifically to determine which chemokine receptors are overexpressed in foetal cells in post-partum women with wounds To do so, the investigators will isolate foetal cells from the peripheral blood of healthy controls post partum women as well as from post partum women with skin ulcers and then perform RNA sequencing.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults. Healthy volunteers may be eligible.
You may be able to join if
- Common criteria :
- Adult women,
- Post-partum: having been pregnant for any length of time,
- Having signed a free and informed consent form,
- Primiparous or multiparous,
You likely can't join if
- Minors (for patients)
- Under court protection, curatorship, guardianship (for patients)
- Immunocompromised patients for any reason whatsoever
- Refusal of consent
- Refusal of blood and/or saliva samples for themselves or a member of their family
See the full eligibility criteria
- Common criteria :
- Adult women,
- Post-partum: having been pregnant for any length of time,
- Having signed a free and informed consent form,
- Primiparous or multiparous,
- Affiliated to a health insurance Patients : \- Patients with a venous, diabetic or sickle cell ulcer, or mixed ulcer Control group patients :
- Volunteers,
- Age-matched,
- Without skin ulcers. There are no specific criteria for children.
- Minors (for patients)
- Under court protection, curatorship, guardianship (for patients)
- Immunocompromised patients for any reason whatsoever
- Refusal of consent
- Refusal of blood and/or saliva samples for themselves or a member of their family
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.